Stay updated on Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial
Sign up to get notified when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.

Latest updates to the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer version label updates from v3.7.2 to v3.8.0, reflecting a ClinicalTrials.gov site release update.SummaryDifference0.1%

- Check23 days agoChange DetectedA banner was added announcing an NIH website transition and noting that NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.9%

- Check30 days agoChange DetectedThe footer site revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check37 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history view updates the label from 'Find Contact Information' to 'Find contact information', and the revision tag changes from v3.6.6 to v3.7.0, reflecting a UI copy standardization and a new version.SummaryDifference0.3%

- Check79 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history. The previous revision v3.6.5 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.